Congratulations to the 27 Department of Medicine faculty who were approved for promotion this year. Their new ranks went into effect on July 1, 2020. 

Clinical Track

Associate Professor

Peter Gill, MD, Hospital Medicine

Joseph Holt, MD, Hospital Medicine

Kraig Kumfer, MD, PhD, Hospital Medicine

Muhammad Shahzeb Munir, MD, Hospital...

Read more

 

Despite large increases in the number of female physicians over the past four decades, there has been no progress in gender integration of the medical specialties over this time. While there are more women in medicine overall, medical trainees continue to distribute into specialties in ways that reinforce pre-existing gender...

Read more

As the COVID-19 outbreak morphed into a pandemic and fear, misinformation, and stigmatization follow closely in its wake, it can be difficult to remember a time 40 years ago when the AIDS epidemic began and those same forces traumatized a community already reeling from the tragic deaths of so many...

Read more

Angulo E, Joyner S, Majeed NK, Nyenhuis S. A rare case of peliosis hepatis in primary immune deficiency. In: SAGE Open Med Case Rep. Vol 8. © The Author(s) 2020.; 2020:2050313x20931996.   Aziz F, Muth B, Parajuli S, Garg N, Mohamed M, Mandelbrot D, Djamali A. Unusually high rates of... Read more

The University of Wisconsin Department of Medicine is proud to honor Kevin McKown, MD, professor (CHS) and division head, Rheumatology, who is retiring on July 1, 2020, after 20 years of service.

UW–Madison Chancellor Rebecca Blank has approved conferral of emeritus status on Dr. McKown.

Dr. McKown joined the department in...

Read more

Research by Amy Kind, MD, PhD, associate professor, Geriatrics and Gerontology, that shares measures of socioeconomic disadvantage at the neighborhood level is now influencing policy on fair allocation of medications to treat patients with COVID-19.

The Neighborhood Atlas, developed by Dr. Kind’s team and launched in 2018, shares...

Read more

On June 14, 2020, the Department of Medicine hosted its first-ever virtual graduation ceremony for the class of 2020 Internal Medicine residents. The ceremony included complimentary remarks about the “extraordinary physician[s]” from Bennett Vogelman, MD, director, Internal Medicine Residency Program, and vice chair for education, Department of Medicine; words of...

Read more

Study objectives: The authors aimed to estimate the false-negative rate of the SARS-CoV-2 RT-PCR by days since infection. Methods and Results: Data from seven previously published studies on reverse transcriptase polymerase chain reaction (RT-PCR) performance by time since symptom onset were included in a pooled analysis. The studies included a...
Abou-Alfa GK, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DV, Borad MJ, Bridgewater J, Harris WP, Murphy AG, Oh DY, Whisenant J, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Fan B, Wu B, Chamberlain CX, Jiang L, Gliser C, Pandya SS, Valle JW...
While the summer break means July is a slower time for most in the University of Wisconsin Department of Medicine, it’s the beginning of the busy season for the department’s promotions team. As another cycle ramps up, administrative team members Amy Alston, HR assistant advanced; Carly Bencke, HR assistant advanced...
When Mariah Quinn, MD, MPH, assistant professor (CHS), General Internal Medicine, assumed the role of Director of Medicine Provider Well-being in 2019, burnout, engagement and work-life-balance were issues being examined at systems and work-environment levels. More recently, as the COVID-19 pandemic disrupted healthcare services and the ways in which we...
Study objectives: Research letter to determine if the Bacillus Calmette–Guérin (BCG) vaccine administered in childhood for tuberculosis reduces the rate of COVID-19 infections. Methods and Results: The BCG vaccine was routinely administered to all newborns in Israel between 1955 and 1982 with high acceptability and coverage amongst citizens. Since 1982...
Background: Protocolized prone positioning has been shown to decrease mortality in patients with severe ARDS requiring mechanical ventilation [2]. Patients with COVID-19 can develop severe hypoxemic respiratory failure, with recent physiologic and autopsy studies showing similar pathophysiology to ARDS [3,4]. Methods: Single-center prospective before-after study of prone positioning in nonintubated...
Purpose: A study to investigate the relationship between underlying cardiovascular disease and COVID-19 outcomes in addition to evaluating the association between cardiovascular drug therapy and mortality in patients with COVID-19. Study Design: Observational study using de-identified data from the Surgical Outcomes Collaborative international registry from 169 hospitals in Asia, Europe...
Alan Bridges, MD, professor (CHS), Rheumatology, senior vice chair, Department of Medicine, and chief of staff at the William S. Middleton Memorial Veterans Hospital, is an expert advisor on post–COVID-19 operations at the Veterans Health Administration (VHA)—at both the national and regional levels. In late April, Dr. Bridges was invited...
Background: Remdesivir is a nucleoside analogue prodrug that has been shown to inhibit human and animal coronaviruses in animal models, and SARS-CoV-2 in vitro. Methods: Randomized, double-blind, placebo-controlled trial in 10 hospitals in Hubei, China [1]. Patients with lab confirmed COVID-19 pneumonia with 12 days or fewer of symptoms were...
Two recent papers published in the New England Journal of Medicine sought to rigorously study the relationship between COVID-19 and antihypertensive medications that impact the renin-angiotensin-aldosterone system (RAAS), including Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs). A link has been suggested on the basis that SARS-CoV-2 enters...